Moderna Skyrockets 100%, Merck Jumps On Late-Stage Cancer Vaccine Trial Win

Moderna skyrocketed and Merck jumped on strong late-stage trial results for their cancer vaccine in melanoma patients Wednesday. The post Moderna Skyrockets 100%, Merck Jumps On Late-Stage Cancer Vaccine Trial Win appeared first on Investor's Business Daily.